Annovis Bio Announces Presentation at International Conference on Alzheimer's & Parkinson's Diseases 2022
- Written by Newsfile
Presentation will Showcase Trial Design in Upcoming Phase 3 Trial in Parkinson's Disease
Berwyn, Pennsylvania--(Newsfile Corp. - March 8, 2022) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing neurodegenerative diseases, today announced that the Company will be presenting at the Interna...